SEC 13F Intelligence

Gtcr LLC / MRVI

Gtcr LLC’s Maravai Lifesciences Hldgs I Position

Does Gtcr LLC own Maravai Lifesciences Hldgs I (MRVI)? Yes — 20.15M shares worth $57M (+1.51% of its 13F portfolio) as of Q1 2026.

Position Value
$57M
Q1 2026
Shares
20.15M
% of Portfolio
+1.51%
Quarters Held
22
currently held

Position History MRVI

Reported value by quarter
Q4 ’20: $775MQ4 ’20Q1 ’21: $985MQ2 ’21: $1.0BQ3 ’21: $1.1BQ3 ’21Q4 ’21: $908MQ1 ’22: $765MQ2 ’22: $616MQ2 ’22Q3 ’22: $554MQ4 ’22: $310MQ1 ’23: $304MQ1 ’23Q2 ’23: $269MQ3 ’23: $217MQ4 ’23: $142MQ4 ’23Q1 ’24: $188MQ2 ’24: $144MQ3 ’24: $167MQ3 ’24Q4 ’24: $110MQ1 ’25: $45MQ2 ’25: $49MQ2 ’25Q3 ’25: $58MQ4 ’25: $65MQ1 ’26: $57MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202620.15M$57M+1.51%
Q4 202520.15M$65M+10.88%
Q3 202520.15M$58M+6.38%
Q2 202520.15M$49M+5.18%
Q1 202520.15M$45M+4.99%
Q4 202420.15M$110M+10.56%
Q3 202420.15M$167M+13.05%
Q2 202420.15M$144M+12.02%
Q1 202421.68M$188M+15.96%
Q4 202321.68M$142M+8.62%
Q3 202321.68M$217M+13.15%
Q2 202321.68M$269M+12.63%
Q1 202321.68M$304M+15.02%
Q4 202221.68M$310M+18.04%
Q3 202221.68M$554M+32.68%
Q2 202221.68M$616M+21.97%
Q1 202221.68M$765M+24.22%
Q4 202121.68M$908M+27.70%
Q3 202121.68M$1.1B+26.99%
Q2 202124.61M$1.0B+28.61%
Q1 202127.65M$985M+27.81%
Q4 202027.65M$775M+19.37%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Gtcr LLC’s full portfolio or all institutional holders of MRVI.